IQVIA Holdings/$IQV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About IQVIA Holdings
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Ticker
$IQV
Sector
Primary listing
NYSE
Employees
94,000
Headquarters
Website
IQVIA Holdings Metrics
BasicAdvanced
$38bn
28.78
$8.08
1.17
-
Price and volume
Market cap
$38bn
Beta
1.17
52-week high
$251.36
52-week low
$154.50
Average daily volume
1.5m
Financial strength
Current ratio
0.706
Quick ratio
0.62
Long term debt to equity
221.346
Total debt to equity
257.975
Interest coverage (TTM)
3.07%
Profitability
EBITDA (TTM)
3,048
Gross margin (TTM)
32.97%
Net profit margin (TTM)
8.10%
Operating margin (TTM)
13.95%
Effective tax rate (TTM)
15.55%
Revenue per employee (TTM)
$180,000
Management effectiveness
Return on assets (TTM)
5.06%
Return on equity (TTM)
22.82%
Valuation
Price to earnings (TTM)
28.778
Price to revenue (TTM)
2.308
Price to book
6.2
Price to tangible book (TTM)
-2.52
Price to free cash flow (TTM)
17.948
Free cash flow yield (TTM)
5.57%
Free cash flow per share (TTM)
12.95
Growth
Revenue change (TTM)
8.17%
Earnings per share change (TTM)
16.67%
3-year revenue growth (CAGR)
4.98%
10-year revenue growth (CAGR)
14.21%
3-year earnings per share growth (CAGR)
11.57%
10-year earnings per share growth (CAGR)
9.28%
What the Analysts think about IQVIA Holdings
Analyst ratings (Buy, Hold, Sell) for IQVIA Holdings stock.
IQVIA Holdings Financial Performance
Revenues and expenses
IQVIA Holdings Earnings Performance
Company profitability
IQVIA Holdings News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.